1. Home
  2. AVBP vs WSR Comparison

AVBP vs WSR Comparison

Compare AVBP & WSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • WSR
  • Stock Information
  • Founded
  • AVBP 2021
  • WSR 1998
  • Country
  • AVBP United States
  • WSR United States
  • Employees
  • AVBP N/A
  • WSR N/A
  • Industry
  • AVBP
  • WSR Real Estate Investment Trusts
  • Sector
  • AVBP
  • WSR Real Estate
  • Exchange
  • AVBP NYSE
  • WSR Nasdaq
  • Market Cap
  • AVBP 617.4M
  • WSR 668.3M
  • IPO Year
  • AVBP 2024
  • WSR 2010
  • Fundamental
  • Price
  • AVBP $20.15
  • WSR $12.57
  • Analyst Decision
  • AVBP Strong Buy
  • WSR Strong Buy
  • Analyst Count
  • AVBP 6
  • WSR 2
  • Target Price
  • AVBP $39.00
  • WSR $16.00
  • AVG Volume (30 Days)
  • AVBP 162.5K
  • WSR 255.7K
  • Earning Date
  • AVBP 05-20-2025
  • WSR 04-30-2025
  • Dividend Yield
  • AVBP N/A
  • WSR 4.11%
  • EPS Growth
  • AVBP N/A
  • WSR 26.93
  • EPS
  • AVBP N/A
  • WSR 0.61
  • Revenue
  • AVBP N/A
  • WSR $155,128,000.00
  • Revenue This Year
  • AVBP $63.13
  • WSR $4.26
  • Revenue Next Year
  • AVBP N/A
  • WSR $4.53
  • P/E Ratio
  • AVBP N/A
  • WSR $20.67
  • Revenue Growth
  • AVBP N/A
  • WSR 6.69
  • 52 Week Low
  • AVBP $15.47
  • WSR $11.78
  • 52 Week High
  • AVBP $36.37
  • WSR $15.36
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 51.13
  • WSR 37.85
  • Support Level
  • AVBP $18.84
  • WSR $12.46
  • Resistance Level
  • AVBP $21.79
  • WSR $12.86
  • Average True Range (ATR)
  • AVBP 1.12
  • WSR 0.29
  • MACD
  • AVBP 0.00
  • WSR -0.01
  • Stochastic Oscillator
  • AVBP 44.50
  • WSR 48.47

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) engaged in owning and operating commercial properties in culturally diverse markets in metropolitan areas. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business friendly locations in and around Austin, Chicago, Dallas-Fort Worth, Houston, Phoenix, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

Share on Social Networks: